Innovation for Health - 13 February 2020
Contact Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Markwin Velders

Vice President Operations & Managing Director, Kite Pharma
Markwin Velders

Session

14:45 - 15:35
Biotech breakthroughs

Dr. Markwin Velders brings over 25 years research experience in the field of tumor immunology and over 15 years of management experience in Biotechnology companies. He obtained his PhD from Leiden University in 1996. After a postdoc and associate professorship at Loyola University in Chicago, he was involved in several start-up companies and became Chief Scientific Officer at AM-Pharma in 2004. After bringing two compounds from bench to bed at AM-Pharma, Markwin moved to TNO Biosciences as a Business Unit Manager, managing a group of 150 people. Since 2011 he has been independently active as Prime Life Science, assisting various start-up and early life science companies with their strategy, financing, business development and interim management. He has been involved in the start-up of several new ventures, and secured funding for 4 Life Sciences start-ups.
At th end of 2013 Markwin became involved with a potential start up from NKI that was incorporated in 2014 and called T-cell Factory (TCF) and he was instrumental in the M&A deal where Kite Pharma Inc. acquired TCF to form Kite Pharma EU B.V. Since March 2015 he is Vice President Operations and Managing Director of Kite Pharma EU B.V. in Amsterdam.

Abstract

Peek into the future of CAR-T and the cellular immunotherapy of cancer
I will present the current status of the CAR-T therapy and the limits and promises of the next generation of CAR-T. However, the cellular therapy is not limited to CAR-T and the current progress of the field opens up the opportunities for new approaches and technologies. How will we attack cancer 10 years from now? New therapies are rapidly developing and some aspects will be discussed.
Dharminder Chalal
SkylineDx
Marcel Levi
University College London Hospitals
Michel Dumontier
Maastricht University
Thijn Brummelkamp
Scenic Biotech
Hans Schikan
Topsector Life Sciences & Health
Inge Huitinga
Netherlands Brain Bank
Sjaak Vink
TheSocialMedwork
Annemarie Jorritsma
NVP
Wiro Niessen
Erasmus MC, TU Delft & Quantib
Tim Knotnerus
AgomAb Therapeutics
Elise Meijer
Antwerp Management School & Accenture Strategy
Esther Talboom-Kamp
Saltro Diagnostics
Joep Muijrers
PureTech Health
Els Beirnaert
Aelin Therapeutics
Carine van den Brink
Axon Lawyers

Claudia Rijcken
pharmi

Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Gold sponsor
Silver sponsor
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.